QW Research
MarketsScreenerInstitutionsInsidersStatusInsightsAPIAboutFAQ
HomeAboutFAQ
Request data / API access →

Data from SEC EDGAR filings: company financials and 13F holdings.

Disclaimer: QW Research is provided for informational and educational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data is derived from public SEC 13F filings and may be incomplete, delayed, or inaccurate. Do not make investment decisions based on this content. QW Research does not share in any profits and accepts no liability for any losses or decisions made using this information. Past performance does not predict future results.

QW Research © 2026

Back to Insiders

Insider trades · 2026-04-19

6 transactions across 1 companies. 0 were decisions — 0 buys ($0) and 0 sales ($0), by 0 and 0 holders. The other 6 are grants, tax withholding, plan sales and option exercises.

Compensation mechanicsGrants, tax withholding, option exercises and pre-arranged plan trades. Shown because they are what most Form 4 volume is, and because they are reported elsewhere as ordinary buying and selling.

HRTX
HERON THERAPEUTICS, INC. /DE/
2 co-filers
Chief Executive Officer
Option exercise13,797——
HRTX
HERON THERAPEUTICS, INC. /DE/
2 co-filers
Chief Executive Officer
Option exercise13,797$0.00—
HRTX
HERON THERAPEUTICS, INC. /DE/
2 co-filers
EVP, Chief Development Officer
Option exercise3,874
holds 185,647 after
——
HRTX
HERON THERAPEUTICS, INC. /DE/
2 co-filers
EVP, Chief Development Officer
Option exercise3,874
holds 27,120 after
$0.00—
HRTX
HERON THERAPEUTICS, INC. /DE/
2 co-filers
EVP, Chief Financial Officer
Option exercise3,874
holds 215,876 after
——
HRTX
HERON THERAPEUTICS, INC. /DE/
2 co-filers
EVP, Chief Financial Officer
Option exercise3,874
holds 27,120 after
$0.00—
← 2026-04-182026-04-20 →

Source: SEC Form 4 filings. Descriptive only — not investment advice.